352 related articles for article (PubMed ID: 10520713)
1. Oncological applications of FDG PET imaging.
Delbeke D
J Nucl Med; 1999 Oct; 40(10):1706-15. PubMed ID: 10520713
[No Abstract] [Full Text] [Related]
2. Where can FDG-PET contribute most to anatomical imaging problems?
Bingham JB
Br J Radiol; 2002 Nov; 75 Spec No():S39-52. PubMed ID: 12519735
[No Abstract] [Full Text] [Related]
3. Clinical role of FDG PET in evaluation of cancer patients.
Kostakoglu L; Agress H; Goldsmith SJ
Radiographics; 2003; 23(2):315-40; quiz 533. PubMed ID: 12640150
[TBL] [Abstract][Full Text] [Related]
4. PET imaging in breast cancer.
Bombardieri E; Crippa F
Q J Nucl Med; 2001 Sep; 45(3):245-56. PubMed ID: 11788817
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography imaging in evaluation of cancer patients.
Kumar R; Bhargava P; Bozkurt MF; Zhuang H; Potenta S; Alavi A
Indian J Cancer; 2003; 40(3):87-100. PubMed ID: 14716112
[TBL] [Abstract][Full Text] [Related]
6. Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET.
Eubank WB; Mankoff DA; Vesselle HJ; Eary JF; Schubert EK; Dunnwald LK; Lindsley SK; Gralow JR; Austin-Seymour MM; Ellis GK; Livingston RB
Radiographics; 2002; 22(1):5-17. PubMed ID: 11796893
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography (PET) in the evaluation of patients with cancer.
Godwin HA; Zuger JH
Trans Am Clin Climatol Assoc; 1999; 110():181-94. PubMed ID: 10344016
[No Abstract] [Full Text] [Related]
8. [The role of positron emission tomography with C18-Fluorodeoxyglucose in clinical oncology].
Granov AM; Tiushin LA; Tlostanova MS; Kostenikov NA; Ryzhkova DV; Savello VE; Stanzhevskiĭ AA
Vopr Onkol; 2003; 49(5):563-73. PubMed ID: 14682126
[TBL] [Abstract][Full Text] [Related]
9. [FDG-PET (positron emission tomography) in the detection of primary breast cancer and lymph node involvement].
Koga S; Nakano S; Honma Y; Ogasawara N
Nihon Rinsho; 2007 Jun; 65 Suppl 6():379-84. PubMed ID: 17682181
[No Abstract] [Full Text] [Related]
10. The value of positron emission tomography in the follow-up for breast cancer.
Siggelkow W; Zimny M; Faridi A; Petzold K; Buell U; Rath W
Anticancer Res; 2003; 23(2C):1859-67. PubMed ID: 12820470
[TBL] [Abstract][Full Text] [Related]
11. Abnormal FDG uptake on 18F-fluorodeoxyglucose positron emission tomography in patients with cancer diagnosis: case reports of tuberculous lymphadenitis.
Ataergin S; Arslan N; Ozet A; Ozguven MA
Intern Med; 2009; 48(2):115-9. PubMed ID: 19145057
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.
Moon DH; Maddahi J; Silverman DH; Glaspy JA; Phelps ME; Hoh CK
J Nucl Med; 1998 Mar; 39(3):431-5. PubMed ID: 9529287
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography for the diagnosis of breast cancer.
Rosé C; Dose J; Avril N
Nucl Med Commun; 2002 Jul; 23(7):613-8. PubMed ID: 12089482
[TBL] [Abstract][Full Text] [Related]
14. Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience.
Hathaway PB; Mankoff DA; Maravilla KR; Austin-Seymour MM; Ellis GK; Gralow JR; Cortese AA; Hayes CE; Moe RE
Radiology; 1999 Mar; 210(3):807-14. PubMed ID: 10207485
[TBL] [Abstract][Full Text] [Related]
15. Utility of the PET-CT scan with (18)F-FDG in a case of choroid melanoma recurrence.
Sabate M; García JR; Valls E; Moragas M; Soler M; Riera E; Lomeña F
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):167-8. PubMed ID: 22177294
[No Abstract] [Full Text] [Related]
16. [Diagnosis of colorectal cancer with FDG-PET].
Uno K
Nihon Rinsho; 2003 Sep; 61 Suppl 7():168-72. PubMed ID: 14574875
[No Abstract] [Full Text] [Related]
17. Value of 18fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma.
Bender H; Kirst J; Palmedo H; Schomburg A; Wagner U; Ruhlmann J; Biersack HJ
Anticancer Res; 1997; 17(3B):1687-92. PubMed ID: 9179219
[TBL] [Abstract][Full Text] [Related]
18. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography and colorectal carcinoma: an update.
Tzimas GN; Koumanis DJ; Meterissian S
J Am Coll Surg; 2004 Apr; 198(4):645-52. PubMed ID: 15051018
[No Abstract] [Full Text] [Related]
20. [Usefulness of 18F-FDG-PET in breast cancer imaging].
Tayama K; Toh U; Fujii T; Shirouzu K; Kaida Y
Nihon Rinsho; 2007 Jun; 65 Suppl 6():373-8. PubMed ID: 17679209
[No Abstract] [Full Text] [Related]
[Next] [New Search]
